Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Beyond dissemination criteria: lesion-based longitudinal MRI of atypical demyelinating lesions at the boundary of multiple sclerosis.

Journal of neurology·2026

Same author

Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Same author

A multicenter, retrospective study in patients with multiple sclerosis treated with natalizumab in a real-world setting in Japan: The REFIND study.

Multiple sclerosis and related disorders·2026

Same author

[Symptoms and Signs of Multiple Sclerosis: Beyond Charcot's Triad].

Brain and nerve = Shinkei kenkyu no shinpo·2025

Same author

B cell depletion as a therapeutic strategy for neuromyelitis optica spectrum disorder: rationale, evidence, and challenges.

Frontiers in immunology·2025

Same author

CD21lo B-cell subsets are recruited to the central nervous system in acute neuromyelitis optica.

Brain : a journal of neurology·2025

Search research articles

Related Experiment Video

Updated: Nov 5, 2025

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

[Acute Disseminated Encephalomyelitis].

Hirofumi Ochi¹, Takeaki Kato

¹Department of Neurology and Geriatric Medicine, Ehime University Graduate School of Medicine.

Brain and Nerve = Shinkei Kenkyu No Shinpo

|May 19, 2021

Summary

Acute disseminated encephalomyelitis (ADEM) is an inflammatory brain disorder primarily affecting children, often following infections or vaccinations. Treatment with high-dose methylprednisolone generally leads to a favorable long-term outcome.

More Related Videos

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

Related Experiment Videos

Last Updated: Nov 5, 2025

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

Area of Science:

Neurology
Immunology
Pediatrics

Background:

Acute disseminated encephalomyelitis (ADEM) is an immune-mediated inflammatory demyelinating disorder of the central nervous system.
It predominantly affects the pediatric population with acute or subacute onset of multifocal neurological symptoms.

Purpose of the Study:

To summarize the key characteristics, triggers, treatment, and prognosis of Acute disseminated encephalomyelitis (ADEM).

Main Methods:

Review of existing literature on ADEM.
Analysis of clinical presentation, etiology, and therapeutic responses.

Main Results:

ADEM is typically monophasic and often associated with preceding infections or vaccinations.
High-dose intravenous methylprednisolone is the first-line therapy.

Conclusions:

The long-term prognosis for pediatric patients with ADEM is generally favorable with appropriate treatment.